These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11347053)

  • 61. [Cardiovascular diseases and lipid abnormalities in Cushing's syndrome].
    Luton JP; Richard C; Laudat MH; Pinon JC; Bricaire H
    Nouv Presse Med; 1982 Sep; 11(36):2693-8. PubMed ID: 7145656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Secondary hyperlipidemia due to endocrine disorders].
    Yoshino G; Maeda E
    Nihon Rinsho; 1990 Nov; 48(11):2565-71. PubMed ID: 2270022
    [No Abstract]   [Full Text] [Related]  

  • 63. Should we evaluate for cardiovascular disease in patients with Cushing's syndrome?
    Fallo F; Sonino N
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):768-71. PubMed ID: 19508589
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Lipid metabolism in Cushing's syndrome].
    Yoshida C; Miyachi Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():177-80. PubMed ID: 11347053
    [No Abstract]   [Full Text] [Related]  

  • 65. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
    De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hyperlipidemia in patients with GH deficiency].
    Hizuka N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():167-71. PubMed ID: 11347051
    [No Abstract]   [Full Text] [Related]  

  • 68. Metabolic syndrome in Cushing's syndrome.
    Chanson P; Salenave S
    Neuroendocrinology; 2010; 92 Suppl 1():96-101. PubMed ID: 20829627
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of diabetes mellitus in Cushing's syndrome.
    Munir A; Newell-Price J
    Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiovascular consequences of cortisol excess.
    Whitworth JA; Williamson PM; Mangos G; Kelly JJ
    Vasc Health Risk Manag; 2005; 1(4):291-9. PubMed ID: 17315601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiovascular risk in Cushing's syndrome.
    Arnaldi G; Mancini T; Polenta B; Boscaro M
    Pituitary; 2004; 7(4):253-6. PubMed ID: 16416038
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Abnormal lipid metabolism in acromegaly].
    Inoue T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():162-6. PubMed ID: 11347050
    [No Abstract]   [Full Text] [Related]  

  • 73. Cushing's syndrome, glucocorticoids and the kidney.
    Smets P; Meyer E; Maddens B; Daminet S
    Gen Comp Endocrinol; 2010 Oct; 169(1):1-10. PubMed ID: 20655918
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glucose and lipid metabolism abnormalities in Cushing's syndrome.
    Salehidoost R; Korbonits M
    J Neuroendocrinol; 2022 Aug; 34(8):e13143. PubMed ID: 35980242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome.
    Després JP
    Exerc Sport Sci Rev; 1997; 25():271-300. PubMed ID: 9213095
    [No Abstract]   [Full Text] [Related]  

  • 76. Management of dyslipidemia in Cushing's syndrome.
    Greenman Y
    Neuroendocrinology; 2010; 92 Suppl 1():91-5. PubMed ID: 20829626
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 78. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lipid disorders in type 2 diabetes.
    Braun LT
    Nurs Clin North Am; 2001 Jun; 36(2):291-302, vii. PubMed ID: 11382564
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.